BIO's Emerging Leaders Workshop Winners

We had a fantastic response to our call for Emerging Leader nominations. Both FierceBiotech and BIO are committed to supporting the next generation of leaders in new product commercialization and this contest is just one small way we're helping them along. Congratulations to our winners:

  • Henry Lowman - Vice President of Research, CytomX Therapeutics 
  • Susan Perkins - Senior Director of Intellectual Property, Avila Therapeutics

Though the contest is over, it's not too late to register. There are a small number of seats still available--register now. Workshop attendees also receive access to the BIO Exhibition Hall. Again, it's a 1.5 day workshop taking place during the 2011 International BIO Convention starting June 27 in Washington, DC. We hope to see you there next week! - Arsalan Arif, Publisher (twitter | email)

Suggested Articles

All 12 members of an FDA advisory committee voted to recommend the approval of teprotumumab for a rare, autoimmune eye disease.

Early data out of former Fierce 15 winner Gritstone Oncology have been heralded as a big win for the early-stage biotech by analysts.

Biogen will drop work on gosuranemab in progressive supranuclear palsy but continue on in Alzheimer's.